proteomic

MedCity Influencers

An Omic Vision of a Diagnostic / Prognostic Future?

An article by Chen et al., published recently in the journal Cell, offers us what Eric Topol has already dubbed “panor-omic” insight into a potential future — one in which our genomic data can be cross-correlated against other “omic” data (including transcriptomic, proteomic, metabolomic, and autoantibody profiles) to give individualized insights into our current clinical […]

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.